(1)
Feasibility Study for the Development of Combination Dosage Form Containing Aspirin and Omeprazole for Treating Cardiovascular and Cerebrovascular Events. Bangla Pharma J 2025, 28 (1), 105-113. https://doi.org/10.3329/bpj.v28i1.79470.